Stay updated on Eravacycline vs Ertapenem in Abdominal Infections Clinical Trial
Sign up to get notified when there's something new on the Eravacycline vs Ertapenem in Abdominal Infections Clinical Trial page.

Latest updates to the Eravacycline vs Ertapenem in Abdominal Infections Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record now presents details for the completed Phase 3 IGNITE1 study comparing eravacycline with ertapenem for complicated intra-abdominal infections, including its eligibility criteria, treatment arms, outcomes, locations, and results-related publications.SummaryDifference59%

- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA sitewide NIH notice announces a website transition and says that “Super Intelligence” will be used in place of “Artificial Intelligence” across some NIH content.SummaryDifference1%

- Check32 days agoChange DetectedThe footer's site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study record page now shows a 403 Forbidden error page instead of the study content, with a standard site header and footer. This indicates that access to the record is blocked.SummaryDifference15%

Stay in the know with updates to Eravacycline vs Ertapenem in Abdominal Infections Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eravacycline vs Ertapenem in Abdominal Infections Clinical Trial page.